Clinical Chemistry

4 February 2020
Dubai World Trade Centre

To further develop a thorough understanding of biomarkers as a clinical and diagnostic tool for surrogate
endpoints in clinical research with the goal of providing context for interpreting studies that rely heavily on such biological measures. Clinical. Chemistry Conference will provide laboratory professionals with latest solutions to their problems while improving quality, turnaround time and technology usage.


Key topics:

  • Clinical diagnostics equipment and kits
  • Novel optical sensors and biosensors
  • Updates in molecular biomarkers
  • Introducing genetic markers
  • Stroke biomarkers discovery

Benefits of attending:

  • Identify latest updates in assays
  • Appraise use of biomarkers in clinical laboratory
  • Review diagnostic and prognostic biomarkers
  • Discuss and evaluate neuroimaging biomarkers

Chairs:

Dr Fayha Ahmed, Consultant and Head of Routine Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE

Dr Laila Abdel Wareth, Chief, Clinical Pathology, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Activity director:

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Speaker faculty:

Prof Abderrazek Hedhili, Professor, Toxicology, Faculty of Pharmacy, Monastir; Faculty of Medicine of Tunis and Health Institutes, Tunis, Tunisia

Dr Brad Karon, Pathologist, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

Prof Damien Gruson, Specialist in Laboratory Medicine, Catholic University of Louvain, Brussels, Belgium

Faisal Ibrahim, QA Director, National Reference Laboratory, Abu Dhabi, UAE

Dr Hamda Abulhoul, Consultant Paediatrics, Al Jalila Children's Specialty Hospital, Dubai, UAE

Dr James H. Nichols, Professor of Pathology, Microbiology and Immunology; Medical Director, Clinical Chemistry and Point-of-Care Testing; Vanderbilt University School of Medicine, Nashville, Tennessee, USA

Dr Marcia Zucker, Consultant, Point of Care Diagnostics; President, ZIVD, Plaistow, New Hampshire, USA 

Dr Mohamed Elsammak, Consultant Chemical Pathologist, Head of the Metabolic Unit, King Fahad Specialist Hospital, Dammam, KSA

Dr Rana Nabulsi, Consultant & Head of Quality, Pathology and Genetics Department, Dubai Health Authority, Dubai, UAE

Dr Riad Abdel Latif Bayoumi, Chairman - Basic Medical Sciences Department, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE

Dr Waleed Tamimi, Head of Clinical Chemistry Lab and POCT, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, KSA